loading page

Pancreatoblastoma in children: EXPeRT/PARTNER diagnostic and therapeutic recommendations.
  • +17
  • Ewa Bien,
  • Jelena Roganovic,
  • MALGORZATA Krawczyk,
  • Jan Godziński,
  • Daniel Orbach,
  • Giovanni Cecchetto,
  • Winfred Barthlen,
  • Anne-Sophie Defachelles,
  • Andrea Ferrari,
  • Christopher Weldon,
  • Ines Brecht,
  • Dominik T. Schneider,
  • Gianni Bisogno,
  • Alexandra Kolenova,
  • Tal Ben-Ami,
  • Kata Martinova,
  • Calogero Virgone,
  • Teresa Stachowicz-Stencel,
  • Denis Kachanov,
  • Yves Reguerre
Ewa Bien
Medical University of Gdansk

Corresponding Author:[email protected]

Author Profile
Jelena Roganovic
Clinical Hospital Center Rijeka, University of Rijeka
Author Profile
Medical University of Gdansk
Author Profile
Jan Godziński
Marciniak Hospital
Author Profile
Daniel Orbach
Institut Curie
Author Profile
Giovanni Cecchetto
University of Padua
Author Profile
Winfred Barthlen
Universitatsmedizin Greifswald
Author Profile
Anne-Sophie Defachelles
Centre Oscar Lambret
Author Profile
Andrea Ferrari
Istituto Nazionale Tumori, Milano
Author Profile
Christopher Weldon
Boston Children's Hospital, Dana-Farber Cancer Institute, & Harvard University
Author Profile
Ines Brecht
University of Tübingen
Author Profile
Dominik T. Schneider
Klinikum Dortmund
Author Profile
Gianni Bisogno
Division of Hematology/Oncology
Author Profile
Alexandra Kolenova
Comenius University - Medical School and University Children’s Hospital
Author Profile
Tal Ben-Ami
Kaplan Medical Center
Author Profile
Kata Martinova
University Clinical Centre Mother Teresa Skopje
Author Profile
Calogero Virgone
University of Padua
Author Profile
Teresa Stachowicz-Stencel
Medical University of Gdansk
Author Profile
Denis Kachanov
National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Samory Mashela str. 1, 117997
Author Profile
Yves Reguerre
Felix Guyon Hospital, St Denis, La Réunion
Author Profile


Pancreatoblastoma (PBL) is a rare malignant epithelial neoplasm affecting typically young children. Signs related to advanced upper-abdominal tumor accompanied by elevated serum α-fetoprotein levels in a young child suggest PBL, however histopathological examination is required for diagnosis. The mainstay of treatment is a complete surgical resection. Inoperable and/or metastatic PBL may become amenable to complete, delayed surgery after neo-adjuvant chemotherapy. This manuscript presents the internationally consensus recommendations for the diagnosis and treatment of children with PBL, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) within the EU-funded PARTNER (Paediatric Rare Tumors Network – European Registry) project.
20 Feb 2021Submission Checks Completed
20 Feb 2021Assigned to Editor
20 Feb 2021Submitted to Pediatric Blood & Cancer
23 Feb 2021Reviewer(s) Assigned
23 Feb 2021Review(s) Completed, Editorial Evaluation Pending
23 Mar 2021Editorial Decision: Revise Major
18 Apr 2021Submission Checks Completed
18 Apr 2021Assigned to Editor
18 Apr 20211st Revision Received
21 Apr 2021Reviewer(s) Assigned
25 Apr 2021Review(s) Completed, Editorial Evaluation Pending
26 Apr 2021Editorial Decision: Accept